Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Enabling Genomic Technologies and Screening Asia 2014

Kosuke Yusa's Biography



Kosuke Yusa, , Welcome Trust Sanger Institute

Kosuke graduated from Osaka University in 1999 with a BSc in Bioengineering and completed an MSc in Agricultural science in 2001 at the University of Tokyo.
In 2005, he obtained his PhD from Osaka University under the supervision of Professor Junji Takeda and received the 'Yamamura prize' (Graduate Student of the Year).
As part of his PhD, Kosuke established a novel forward genetic screening method in mouse ES cells that uses the hyper-recombination phenotype of Bloom helicase-deficient cells.
After his PhD, he was awarded a post-doctoral fellowship from the Japan Society of Promotion of Science and joined Professor Allan Bradley's team at the Sanger Institute in 2007.
He has developed the hyperactive piggyBac 'jumping gene' (DNA transporter system) and used it to create a novel platform of iPS cell reprogramming.
By combining this system with zinc finger nuclease technology, he has achieved highly precise genetic correction of disease-causing mutations in human iPS cells, opening the way to new clinical treatments.
In October 2012, Kosuke was appointed as a member of the Sanger Institute Faculty in the newly developed scientific programme, Cellular Genetics.

Kosuke Yusa Image

Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library

Friday, 12 September 2014 at 09:00

Add to Calendar ▼2014-09-11 00:00:002014-09-11 01:00:00Europe/LondonEnabling Genomic Technologies and Screening Asia 2014 in SingaporeSingaporeSELECTBIOenquiries@selectbiosciences.com

The CRISPR-Cas system is an emerging new technology for genome editing. Its flexibility and scalability enable us to use this system as a functional genomics tool. We have constructed genome-wide lentiviral CRISPR libraries and conducted loss-of-function screens to identify genes that modulate cellular susceptibility to cytotoxic reagents such as a toxin. Our results highlight a wide applicability of the CRISPR-Cas9 system.


Agenda is not currently available
Add to Calendar ▼2014-09-11 00:00:002014-09-12 00:00:00Europe/LondonEnabling Genomic Technologies and Screening Asia 2014Enabling Genomic Technologies and Screening Asia 2014 in SingaporeSingaporeSELECTBIOenquiries@selectbiosciences.com